Playback speed
10 seconds
Video Player is loading.
Current Time 0:00
/
Duration 0:00
Loaded: 0%
Stream Type LIVE
Remaining Time -0:00
1x
- 0.5x
- 0.75x
- 1x, selected
- 1.25x
- 1.5x
- 1.75x
- 2x
- Chapters
- descriptions off, selected
- captions settings, opens captions settings dialog
- captions off, selected
This is a modal window.
Beginning of dialog window. Escape will cancel and close the window.
End of dialog window.
This is a modal window. This modal can be closed by pressing the Escape key or activating the close button.
Unmet Needs and Resistance Mechanisms in Patients With HR+, HER2- MBC Who Progress on 1L CDK4/6 Inhibitors in Combination With Endocrine Therapy
By
Lilly Medical Affairs
FEATURING
Wassim Mchayleh
By
Lilly Medical Affairs
FEATURING
Wassim Mchayleh
473 views
November 7, 2024
In this video, Dr. Wassim Mchayleh shares his insights on the unmet needs and challenges faced in HR+, HER2- MBC, including the emergence of resistance mechanisms to ET, either alone or in combination with CDK4/6i.
To access additional videos and download free resources, click here.
VV-OTHR-US-DEL-3129 © 2024 Lilly USA, LLC. All Rights Reserved.
Comments are disabled for this content.